Skip to content

Postprandial effects of a low vs. a high glycemic index food product on metabolic risk markers in lean and obese men

Postprandial effects of a low vs. a high glycemic index food product on metabolic risk markers in lean and obese men - Postprandial effects of low-GI food products on metabolic risk markers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31524
Enrollment
30
Registered
2008-02-06
Start date
2008-02-22
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty degeneration obesity

Interventions

2 mornings consumption of low- or high-GI cookie 2 mornings consumption of glucose solution

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Lean (BMI 20-25kg/m²) as well as obese (BMI 30-35 kg/m²) non-smoking men, aged 18-65. Because smoking might influence inflammatory parameters we will use non-smokers.

Exclusion criteria

Exclusion criteria: - unstable body weight (weight gain or loss >3 kg in the past 3 months) - Quetelet-index (BMI) 25 kg/m2 or 35 kg/m2 - diabetes mellitus and anti-diabetic medication (e.g. PPARγ agonists) - severe medical conditions that might interfere with the study such as hypertension, epilepsy, astma, COPD, inflammatory bowel diseases and rheumatoid arthritis, autoimmune disorders, allergies - use of medication or a diet known to affect serum lipid levels - history of coronary heart disease - abuse of drugs and/or alcohol - smoking - women - use of an investigational product within the previous 30 days - not willing to give up being a blood donor from 4 weeks before the start of the study and during the study. - impossible of difficult to venipuncture

Design outcomes

Primary

MeasureTime frame
IL-6

Secondary

MeasureTime frame
Is there a difference between lean and obese subjects in metabolic risk markers after consuming a low- or high-GI food product?

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)